These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 18253926)

  • 1. Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores.
    Monnier N; Marty I; Faure J; Castiglioni C; Desnuelle C; Sacconi S; Estournet B; Ferreiro A; Romero N; Laquerriere A; Lazaro L; Martin JJ; Morava E; Rossi A; Van der Kooi A; de Visser M; Verschuuren C; Lunardi J
    Hum Mutat; 2008 May; 29(5):670-8. PubMed ID: 18253926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene.
    Jungbluth H; Zhou H; Hartley L; Halliger-Keller B; Messina S; Longman C; Brockington M; Robb SA; Straub V; Voit T; Swash M; Ferreiro A; Bydder G; Sewry CA; Müller C; Muntoni F
    Neurology; 2005 Dec; 65(12):1930-5. PubMed ID: 16380615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First genomic rearrangement of the RYR1 gene associated with an atypical presentation of lethal neonatal hypotonia.
    Monnier N; Laquerrière A; Marret S; Goldenberg A; Marty I; Nivoche Y; Lunardi J
    Neuromuscul Disord; 2009 Oct; 19(10):680-4. PubMed ID: 19734047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central core disease is due to RYR1 mutations in more than 90% of patients.
    Wu S; Ibarra MC; Malicdan MC; Murayama K; Ichihara Y; Kikuchi H; Nonaka I; Noguchi S; Hayashi YK; Nishino I
    Brain; 2006 Jun; 129(Pt 6):1470-80. PubMed ID: 16621918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia.
    Romero NB; Monnier N; Viollet L; Cortey A; Chevallay M; Leroy JP; Lunardi J; Fardeau M
    Brain; 2003 Nov; 126(Pt 11):2341-9. PubMed ID: 12937085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies.
    Zhou H; Jungbluth H; Sewry CA; Feng L; Bertini E; Bushby K; Straub V; Roper H; Rose MR; Brockington M; Kinali M; Manzur A; Robb S; Appleton R; Messina S; D'Amico A; Quinlivan R; Swash M; Müller CR; Brown S; Treves S; Muntoni F
    Brain; 2007 Aug; 130(Pt 8):2024-36. PubMed ID: 17483490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation.
    Sato I; Wu S; Ibarra MC; Hayashi YK; Fujita H; Tojo M; Oh SJ; Nonaka I; Noguchi S; Nishino I
    Neurology; 2008 Jan; 70(2):114-22. PubMed ID: 17538032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene.
    Ferreiro A; Monnier N; Romero NB; Leroy JP; Bönnemann C; Haenggeli CA; Straub V; Voss WD; Nivoche Y; Jungbluth H; Lemainque A; Voit T; Lunardi J; Fardeau M; Guicheney P
    Ann Neurol; 2002 Jun; 51(6):750-9. PubMed ID: 12112081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central core disease due to recessive mutations in RYR1 gene: is it more common than described?
    Kossugue PM; Paim JF; Navarro MM; Silva HC; Pavanello RC; Gurgel-Giannetti J; Zatz M; Vainzof M
    Muscle Nerve; 2007 May; 35(5):670-4. PubMed ID: 17226826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene.
    Fischer D; Herasse M; Ferreiro A; Barragán-Campos HM; Chiras J; Viollet L; Maugenre S; Leroy JP; Monnier N; Lunardi J; Guicheney P; Fardeau M; Romero NB
    Neurology; 2006 Dec; 67(12):2217-20. PubMed ID: 17190947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of ryanodine receptor (RYR1) sequence variants using a metabolic assay in immortalized B-lymphocytes.
    Zullo A; Klingler W; De Sarno C; Ferrara M; Fortunato G; Perrotta G; Gravino E; Di Noto R; Lehmann-Horn F; Melzer W; Salvatore F; Carsana A
    Hum Mutat; 2009 Apr; 30(4):E575-90. PubMed ID: 19191333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families.
    Barone V; Massa O; Intravaia E; Bracco A; Di Martino A; Tegazzin V; Cozzolino S; Sorrentino V
    J Med Genet; 1999 Feb; 36(2):115-8. PubMed ID: 10051009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital myopathies].
    Cabello A; Ricoy-Campo JR
    Rev Neurol; 2003 Oct 16-31; 37(8):779-86. PubMed ID: 14593641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.
    Monnier N; Kozak-Ribbens G; Krivosic-Horber R; Nivoche Y; Qi D; Kraev N; Loke J; Sharma P; Tegazzin V; Figarella-Branger D; Roméro N; Mezin P; Bendahan D; Payen JF; Depret T; Maclennan DH; Lunardi J
    Hum Mutat; 2005 Nov; 26(5):413-25. PubMed ID: 16163667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in RYR1 in malignant hyperthermia and central core disease.
    Robinson R; Carpenter D; Shaw MA; Halsall J; Hopkins P
    Hum Mutat; 2006 Oct; 27(10):977-89. PubMed ID: 16917943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype correlations in recessive RYR1-related myopathies.
    Amburgey K; Bailey A; Hwang JH; Tarnopolsky MA; Bonnemann CG; Medne L; Mathews KD; Collins J; Daube JR; Wellman GP; Callaghan B; Clarke NF; Dowling JJ
    Orphanet J Rare Dis; 2013 Aug; 8():117. PubMed ID: 23919265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations.
    Jungbluth H; Davis MR; Müller C; Counsell S; Allsop J; Chattopadhyay A; Messina S; Mercuri E; Laing NG; Sewry CA; Bydder G; Muntoni F
    Neuromuscul Disord; 2004 Dec; 14(12):785-90. PubMed ID: 15564033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing the number of diagnostic mutations in malignant hyperthermia.
    Levano S; Vukcevic M; Singer M; Matter A; Treves S; Urwyler A; Girard T
    Hum Mutat; 2009 Apr; 30(4):590-8. PubMed ID: 19191329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization.
    Guis S; Figarella-Branger D; Monnier N; Bendahan D; Kozak-Ribbens G; Mattei JP; Lunardi J; Cozzone PJ; Pellissier JF
    Arch Neurol; 2004 Jan; 61(1):106-13. PubMed ID: 14732627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.